期刊文献+

外周血淋巴细胞转化生长因子β1 mRNA表达与慢性移植物肾病的关系

Relation of TGF-β1 mRNA expression in peripheral blood lymphocyte and chronic allograft nephropathy
原文传递
导出
摘要 目的研究转化生长因子β1(TGF-β1)在慢性移植物肾病(CAN)发生发展中的作用以及免疫抑制剂对TGF-β1的影响。方法采用实时荧光定量PCR检测15例CAN和22例非CAN患者外周血淋巴细胞TGF-β1 mRNA表达,分析CAN、免疫抑制剂和TGF-β1 mRNA表达3者之间的关系。结果CAN组TGF-β1 mRNA表达明显高于非CAN组,分别为0.1 55±0.027和0.123±0.028(P〈0.01)。服用环孢素(CsA)的患者TGF-β1 mRNA表达明显高于服用他克莫司(FK506)者,CAN组分别为0.170和0.137(P〈0.01),非CAN组分别为0.135和0.106(P〈0.01)。TGF-β1 mRNA表达与肾移植受者血肌酐(r2=0.77,P〈0.01)和血尿素氮(r2=0.63,P〈0.01)呈良好线性关系。结论CsA能引起肾移植受者外周血淋巴细胞TGF-β1 mRNA高表达,后者可诱发和促进CAN的发生与发展。 Objective To study the relation of TGF-β1 in the development and progression of chronic allograft nephropathy (CAN) and the effect of immunosuppressants on TGF-β1. Methods The expression of TGF-β1 mRNA in peripheral blood lymphocyte(PBL) was detected in 15 CAN pa dents and 22 non-CAN patients, who were divided into CsA or FK506 groups respectively. The relation of CAN development, TGF-β1 expression and immunosuppressant were observed. Results The expression of TGF-β1 mRNA was higher in CAN group than that in non CAN group significantly, 0.155±0.027 vs 0. 123±0. 028, P(0. 01. The expression of TGF-β1 mRNA was higher in CsA group than that in FK506 group, 0. 170 and 0. 137 in CAN group, and 0. 135 and 0. 106 in non-CAN group, both P〈0.01. The expression of TGF-β1 mRNA was negative correlated with allograft func tion, P〈0.01. Conclusions CsA is related to the higher expression of TGF-β1 mRNA, which may induce the development of CAN.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2007年第7期475-477,共3页 Chinese Journal of Urology
关键词 慢性移植物肾病 转移生长因子Β1 免疫抑制剂 Chronic allograft nephropathy Transforming growth factor-β1 Immunosuppressant
  • 相关文献

参考文献11

  • 1Ruggenenti P. Chronic allograft nephropathy. A multiple approach to target nonimmunological factors. Contrib Nephrol, 2005,146:87-94.
  • 2Solez K, Vincenti F, Filo RS. Histopathologic findings from 2-year protocol biopsies from a U. S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FKS06 Kidney Transplant Study Group. Transplantation, 1998,66 : 1736-1740.
  • 3Kist van Holthe JE, Gasser M, Womer K, et al. Regulatory functions of alloreactive Th2 clones in human renal transplant recipients. Kidney Int,2002,62:627-631.
  • 4Weller PF. Human eosinophils. J Allergy Clin Immunol, 1997,100:283-287.
  • 5Johnson DW, Saunders H J, Johnson FJ, et al. Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells: roles of insulin-like growth factor 1, transforming growth factor beta 1, and platelet derived growth factor. J Pharmacol Exp Ther, 1999,289:535-542.
  • 6Mas VR, Alvarellos T, Maluf DG, et al. Molecular and clinical response to angiotensin Ⅱ receptor antagonist in kidney transplant patients with chronic allograft nephropathy. Transpl Int,2004,17:540-544.
  • 7Abdel-Wahab N, Weston BS, Roberts T, et al. Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy. J Am Soc Nephrol, 2002,13: 2437-2445.
  • 8Paul LC. Chronic rejection of organ allografts: magnitude of the problem. Transplant Proc, 1993,25 : 2024-2025.
  • 9Islam M, Burke JF Jr, McGowan TA, et al. Effect of antitransforming growth factor beta 1 antibodies in cyclosporine-induced renal dysfunction. Kidney Int, 2001,59 : 498-506.
  • 10Lario S, Mendes D, Bescos M, et al. Expression of transforming growth factor beta 1 and hypoxia inducible factor-1 alpha in an experimental model of kidney transplantation. Transplantation, 2003,75 : 1647-1654.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部